Ferric carboxymaltose assessment of morbidity and mortality in patients with iron deficiency and chronic heart failure (FAIR‐HF2‐DZHK05) trial: Baseline characteristics and comparison to other relevant clinical trials.
Saved in:
| Title: | Ferric carboxymaltose assessment of morbidity and mortality in patients with iron deficiency and chronic heart failure (FAIR‐HF2‐DZHK05) trial: Baseline characteristics and comparison to other relevant clinical trials. |
|---|---|
| Authors: | Anker, Stefan D.1,2 (AUTHOR) s.anker@cachexia.de, Friede, Tim3,4 (AUTHOR), Butler, Javed5,6 (AUTHOR), Talha, Khawaja M.7 (AUTHOR), Placzek, Marius3 (AUTHOR), Diek, Monika1,2 (AUTHOR), Nosko, Anna8 (AUTHOR), Stas, Adriane4,9 (AUTHOR), Kluge, Stefan8 (AUTHOR), Jarczak, Dominik8 (AUTHOR), Deheer, Geraldine8 (AUTHOR), Rybczynski, Meike10,11 (AUTHOR), Bayes‐Genis, Antoni12 (AUTHOR), Edelmann, Frank13,14 (AUTHOR), Filippatos, Gerasimos15 (AUTHOR), Hasenfuß, Gerd4,16 (AUTHOR), Haverkamp, Wilhelm1,2 (AUTHOR), Lainscak, Mitja17,18 (AUTHOR), Landmesser, Ulf14,19 (AUTHOR), Macdougall, Iain C.20 (AUTHOR) |
| Source: | European Journal of Heart Failure. Aug2025, Vol. 27 Issue 8, p1436-1443. 8p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
